USE OF A CONTRACEPTIVE VAGINAL RING GOVERNED BY THE PATTERN OF INDIVIDUAL UTERINE BLEEDING

被引:8
作者
TOIVONEN, J
LAHTEENMAKI, P
LUUKKAINEN, T
机构
[1] Steroid Research Laboratory, Department of Medical Chemistry, University of Helsinki
关键词
D O I
10.1016/0010-7824(79)90034-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Contraceptive vaginal rings (CVR) releasing levonorgestrel and estradiol were used for contraceptive purposes in eight women. They were instructed to remove the CVR for five days only, in the case of bleeding. Three selected subjects were followed by plasma sampling during the first 60 days of treatment. Plasma concentrations of levonorgestrel, progesterone, estradiol and gonadotropins were determined. All subjects kept bleeding records and were controlled clinically in the course of treatment. The subjects were protected an average of 163 days by the CVR. Three subjects used the CVR 170-180 days without removing it and two subjects had to remove the CVR only once. Two subjects experienced quite regular bleedings, and metrorrhagic bleeding was present in one case. No pregnancies were observed during the follow-up period of 1304 days. Clinical examination revealed no pathological findings. The vaginal mucosa tolerated the treatment well. Out of those subjects who were followed by plasma sampling, pituitary suppression was more marked in the subject with continuous use of CVR. © 1979.
引用
收藏
页码:401 / 409
页数:9
相关论文
共 11 条
[1]   EVALUATION OF DOUBLE ANTIBODY-SOLID PHASE RADIOIMMUNOASSAY TECHNIQUE IN PLASMA LH AND FSH AND URINARY LH MEASUREMENTS [J].
KARONEN, SL ;
LAHTEENMAKI, P ;
HOHENTHAL, U ;
ADLERCREUTZ, H .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1978, 38 (02) :97-106
[2]  
LAHTEENMAKI P, 1978, SCAND J CLIN LAB INV, V38, P1
[3]   CLINICAL PERFORMANCES AND ENDOCRINE PROFILES WITH CONTRACEPTIVE VAGINAL RINGS CONTAINING D-NORGESTREL [J].
MISHELL, DR ;
ROY, S ;
MOORE, DE ;
BRENNER, PF ;
PAGE, MA ;
GENTZSCHEIN, E ;
FISK, PD .
CONTRACEPTION, 1977, 16 (06) :625-636
[4]  
MISHELL DR, 1970, AM J OBSTET GYNECOL, V107, P100
[5]   INITIAL CLINICAL STUDIES OF INTRAVAGINAL RINGS CONTAINING NORETHINDRONE AND NORGESTREL [J].
MISHELL, DR ;
LUMKIN, M ;
JACKANICZ, T .
CONTRACEPTION, 1975, 12 (03) :253-260
[6]   CLINICAL PERFORMANCE AND ENDOCRINE PROFILES WITH CONTRACEPTIVE VAGINAL RINGS CONTAINING A COMBINATION OF ESTRADIOL AND D-NORGESTREL [J].
MISHELL, DR ;
MOORE, DE ;
ROY, S ;
BRENNER, PF ;
PAGE, MA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1978, 130 (01) :55-62
[7]   RADIOIMMUNOASSAY OF SERUM D-NORGESTREL IN WOMEN FOLLOWING ORAL AND INTRAVAGINAL ADMINISTRATION [J].
STANCZYK, FZ ;
HIROI, M ;
GOEBELSMANN, U ;
BRENNER, PF ;
LUMKIN, ME ;
MISHELL, DR .
CONTRACEPTION, 1975, 12 (03) :279-298
[8]   PITUITARY AND GONADAL FUNCTION DURING USE OF NORGESTREL-ESTRADIOL VAGINAL RINGS [J].
TOIVONEN, J ;
LAHTEENMAKI, P ;
LUUKKAINEN, T .
CONTRACEPTION, 1978, 18 (03) :201-211
[9]   CONTRACEPTIVE RINGS - SELF-ADMINISTERED TREATMENT GOVERNED BY BLEEDING [J].
VICTOR, A ;
JOHANSSON, EDB .
CONTRACEPTION, 1977, 16 (02) :137-147
[10]   PLASMA-LEVELS OF D-NORGESTREL AND OVARIAN-FUNCTION IN WOMEN USING INTRAVAGINAL RINGS IMPREGNATED WITH DI-NORGESTREL FOR SEVERAL CYCLES [J].
VICTOR, A ;
JOHANSSON, EDB .
CONTRACEPTION, 1976, 14 (02) :215-226